جميع الدراسات
التوظيفاستكشاف علاجي (المرحلة الثانية)تداخلي

A Phase 2a, Randomized, Placebo-controlled, Dose-Ranging Study to Evaluate the Safety and Efficacy of PTC518 in Subjects with Huntington’s Disease

This study is looking into a new medication called PTC518 for people living with Huntington's Disease. It's a 'Phase 2a' study, which means researchers are carefully checking its safety and how effective it might be at different doses. Some participants will receive the active medicine, while others will get a placebo (a dummy pill that looks the same but contains no medicine). This helps researchers understand the true effects of PTC518. They will monitor changes in a specific protein in the blood related to Huntington's Disease, as well as checking for any side effects and other health markers. The aim is to find a safe and effective dose.

نظرة سريعة

الحالة
التوظيف
المرحلة
استكشاف علاجي (المرحلة الثانية)
الراعي
PTC Therapeutics Inc.
الهدف من التسجيل
121
ابدأ
06 مايو 2024

ما هو موضوع هذه الدراسة؟

This clinical trial is exploring a new potential treatment called PTC518 for Huntington's Disease. Huntington's is a complex condition, and scientists are constantly working to find better ways to manage it. This particular study is in an early stage, known as Phase 2a, which focuses on thoroughly checking the safety of the new medicine and trying to work out the best dose to use.

Participants in the study will be split into different groups. Some will receive PTC518 at varying doses, while others will receive a 'placebo'. A placebo is a dummy pill that looks exactly like the real medicine but contains no active ingredients. This is a common and important part of clinical research because it helps researchers understand if the changes they see are truly due to the medicine or if they might happen anyway.

The main things researchers will be looking at are safety — checking for any unwanted side effects and general health changes — and how the medicine affects a specific protein in the blood that is linked to Huntington's Disease. They will also look at how the medicine might impact brain structure and general physical and mental health over time. This information will help them decide if PTC518 is a promising treatment and if it should be tested in larger studies.

النقاط الرئيسية

  • This study is testing a new medicine (PTC518) for Huntington's Disease.
  • It's a safety and dose-finding study (Phase 2a).
  • Participants will receive either the active medicine or a dummy pill (placebo).
  • Researchers will monitor safety, a specific protein in the blood, and other health markers.
  • The study lasts for 12 months and involves regular clinic visits and tests.
  • المشاركة طوعية، ويمكنك الانسحاب في أي وقت.

من قد يكون مؤهلاً؟

To be considered for this study, you must be an adult, aged 18 years or older, with Huntington's Disease. Both men and women can take part.

There might be other specific health requirements or conditions that would mean you couldn't join the study, even if you meet the age and diagnosis criteria. These detailed rules are in place to make sure the study is as safe as possible for everyone involved and that the results are clear and reliable.

If you're interested, it's really important to discuss this with your doctor or the study team, as they will be able to check all the specific eligibility rules with you.

هل يمكن أن تناسبك هذه الدراسة؟

أجب عن هذه الأسئلة السريعة لترى ما إذا كنت مؤهلاً. هذا دليل فقط - الفريق البحثي هو الذي يتخذ القرار النهائي.

  1. هل عمرك 18 سنة أو أكثر؟
  2. Have you been diagnosed with Huntington's Disease?
  3. Are you able to attend regular clinic appointments and undergo study tests?
  4. Are you willing to consider taking either the study medicine or a placebo?
أجب عن كل سؤال لترى نتيجتك.

ماذا يتضمن المشاركة؟

If you decide to take part in this study, you'll be assigned to a group that receives either the study medicine (PTC518) or a placebo (a dummy pill). You won't know which one you're getting, and neither will your study doctor, as this helps make the results fair. You'll take the assigned tablets regularly as instructed. Over the course of the study, you'll have several visits to the clinic.

During these visits, the study team will conduct various assessments. This includes regular checks of your general health, blood tests to look at the protein related to Huntington's and other markers, heart checks (using an ECG), and physical examinations. They will also talk to you about how you're feeling, including any side effects, and assess changes in your symptoms or mood using specific questionnaires.

Some assessments, like brain scans (MRI), will be done a bit less frequently, at specific time points like after 12 months. The study will last for a total of 12 months, with ongoing monitoring and assessment throughout this period.

المخاطر والفوائد المحتملة

Participating in a clinical trial offers potential benefits, such as contributing to new medical knowledge and potentially receiving a new treatment for your condition, which might improve your health. However, there are also potential risks, including side effects from the investigational medication, or the inconvenience of frequent clinic visits and tests. There's no guarantee the treatment will help you. You have the right to withdraw from the study at any time, for any reason, without it affecting your medical care.

المواقع (6)

بعض مواقع الأماكن تقريبية. نحن نعمل على تحسين ذلك — يرجى التحقق مع فريق التجربة قبل السفر.
  • —
    غير مؤكد
    ألمانيا
  • —
    غير مؤكد
    إسبانيا
  • —
    غير مؤكد
    إيطاليا
  • —
    غير مؤكد
    النمسا
  • —
    غير مؤكد
    هولندا
  • —
    غير مؤكد
    فرنسا

أسئلة شائعة

What is Huntington's Disease?

Huntington's Disease is a genetic condition that affects the brain, causing uncontrolled movements, mental health issues, and a decline in thinking skills over time.

What does 'Phase 2a' mean?

Phase 2a means this is an early stage of testing where researchers are checking if the medicine is safe, how well it works, and what dose might be best.

ما هو الدواء الوهمي؟

A placebo is a 'dummy pill' that looks exactly like the real medicine but contains no active ingredients. It helps researchers understand the true effects of the medicine.

هل سأعرف إذا كنت أحصل على الدواء الحقيقي؟

No, neither you nor your study doctor will know if you're getting the medicine or the placebo. This is to ensure the study results are fair and accurate.

كم ستستغرق مدة الدراسة؟

The main part of this study will involve taking the study drug and having follow-up appointments over 12 months.

كيفية معرفة المزيد

تحدث دائمًا إلى طبيبك العام أو الأخصائي قبل اتخاذ قرار بالمشاركة في دراسة.

هل أنت مهتم بالمشاركة؟

سجل اهتمامك

شارك تفاصيلك وفريق البحث لـ "A Phase 2a, Randomized, Placebo-controlled, Dose-Ranging Stu… "سيتواصل معك إذا كنت مؤهلاً. تحدث دائمًا إلى طبيبك قبل الموافقة على المشاركة.

نقاش

مناقشة المجتمع

مدعوم من منتدانا في community.patient.info. يرجى التحلي بالاحترام — هذه ليست نصيحة طبية.